Table of Contents
1. Sleep Disorders: An Introduction
- 1.1 Sleep Cycle
- 1.2 Amount of Sleep Required
- 1.3 Sleep Disorders
- 1.4 Insomnia
- 1.5 Sleep Apnea
- 1.6 Narcolepsy
- 1.7 Restless Legs Syndrome
- 1.8 Treatment & Diagnosis
2. Market Overview
- 2.1 Worldwide Market
- 2.2 US Market
3. OSA Market
- 3.1 Sleep Disordered Breathing Market Breakup
- 3.2 US Market for OSA Treatment
4. Insomnia Market
5. Market Trends
- 5.1 Use of Actigraphy for Sleep Disorder Evaluation
- 5.2 Alternative Medicines for Insomnia
- 5.3 Opportunities for HME Providers
- 5.4 Increasing Sleep Centers
6. Demographic Trends
- 6.1 Sleep Disorders in Older People
- 6.2 Sleep Disorders in Women
- 6.3 Sleep Disorders in Children
- 6.4 Sleep Concerns of Employees
7. Competitive Landscape
- 7.1 Insomnia Market
- 7.1.1 Drugs in Pipeline for Insomnia
- 7.1.2 Insomnia Market Activity
- 7.1.3 Marketers of Insomnia Drugs
- 7.1.4 Insomnia Market Share
- 7.1.5 Characteristics of Drugs
- 7.2 OSA Market
- 7.2.1 OSA Sales & Market Share
- 7.2.2 Worldwide Market
- 7.2.3 US Market
8. Company Profiles
- 8.1 Respironics
- 8.1.1 Overview
- 8.1.2 Business Strategies
- 8.1.3 Product Innovation
- 8.1.4 Strong Distribution Network
- 8.1.5 International Growth
- 8.2 ResMed
- 8.2.1 Overview
- 8.2.1 Business Strategies
- 8.2.1 Continued Product Development and Innovation
- 8.2.1 Increase Public and Clinical Awareness
- 8.2.1 Expansion into New Clinical Applications
- 8.3 Neurocrine
- 8.3.1 Overview
- 8.3.2 Business Strategies
- 8.3.3 Building Product Portfolio
- 8.3.4 Identifying Novel Drug Targets
- 8.4 Neurogen
- 8.4.1 Overview
- 8.4.2 Business Strategies
- 8.4.3 Pursue a Risk-balanced Drug Portfolio
- 8.4.4 Partnering at Optimal Stages
- 8.4.5 Focus on Specialist Care Indications
List of Charts
- Total Sleep/Day by Age Group
- Classification of Sleep Disorders
- Worldwide Market for Sleep Disorder Treatment (2004-10E)
- US Sleep Diagnostic/Treatment Device Market (2005-07E)
- US Market for OSA Treatment (2003-07E)
- Sleep Disordered Breathing Market Breakup
- Insomnia Market Share - Drug Classes (2006)
- Non-Benzo/Non-Barbituate Market Share (2007)
List of Tables
- Sleep Disorder Facilities in the US (1996-2007)
- Employees Survey - Causes of Sleep Disturbance
- Drugs in Pipeline for Insomnia
- Insomnia Market Activity (2007)
- Current/Potential Marketers of Insomnia Drugs
- Characteristics of Drugs Marketed For Insomnia
- OSA Market Leaders - Market Share (2005-09E)
- OSA Market Leaders -US & International Sales (2005-09E)
- ResMed - CPAP Products
- Neurocrine - Product Pipeline
- Neurogen - Clinical Development Programs
|
Related Report
|
View Cart
